
Comprehensive Diagnosis & Genomic Assessments
Tailored Evaluations to Enhance Your Mental Health Care
At New Path Psychiatry,
We combine expert diagnostic services with genomic assessments to create personalized treatment plans for our clients. Genomic assessments are particularly valuable for those who have experienced severe anxiety or have had difficulties with SSRIs, either due to lack of success or numerous side effects.
These assessments, conducted in partnership with Genomind, provide insights into how your body responds to medications, helping us tailor your treatment for better outcomes.
Importance of Diagnosis & Genomic Assessments:
Genomic assessments can be a powerful tool for those facing significant challenges with standard treatments. By understanding your genetic makeup, we can offer a more personalized approach to medication management, reducing the trial-and-error process and enhancing the effectiveness of your treatment.
Our Process for Genomic Assessments
Step 1: Initial Evaluation
During your initial evaluation at New Path Psychiatry, we’ll discuss your symptoms, treatment history, and whether a genomic assessment might be beneficial for you.
Step 2: Determine Suitability
We’ll have a detailed conversation with you to determine if a genomic assessment is the right choice based on your specific needs and challenges.
Step 3: Setting Up the Assessment
If we decide to proceed, we’ll contact Genomind to arrange your genomic assessment. Genomind is a trusted external partner specializing in genomic testing for mental health.
Step 4: Sample Collection & Analysis
They’ll guide you through the process of collecting your genetic sample (saliva swab), which will then be sent to Genomind for analysis.
Step 5: Review & Next Steps
Once we receive your results, our team will work closely with you to interpret the findings and integrate them into your treatment plan, taking the next steps toward optimized care.
Who Can Benefit from Genomic Assessments?
Clients with Severe Anxiety:
If you’re experiencing severe anxiety and standard treatments haven’t worked, a genomic assessment might help identify more effective options.
Those with SSRI Challenges:
If you’ve tried SSRIs with little success or significant side effects, a genomic assessment can provide insights into alternative medications that may be better suited for you.
Common Questions
-
A genomic assessment analyzes how your genes may affect your response to psychiatric medications, helping to personalize your treatment plan.
-
This assessment is typically recommended for clients with severe anxiety or those who have had difficulties with SSRIs. Please note these are not exclusive as other conditions may apply where genomic assessments are recommended. These are just the most common reasons we see.
-
Genomind’s assessment involves fees that are managed directly between Genomind and the client. Please go to their website to find more information about fees.
-
While it provides valuable insights, it’s not a guarantee since genomic assessments are not an exact science and utilize data from a sampling of the population with similar genes. However, it can significantly improve the likelihood of finding an effective treatment.
-
Many insurance plans offer partial coverage for Genomind’s services. Check their Cost and Coverage page for details.
-
The process involves an initial evaluation, a discussion to determine suitability, sample collection, and a review of results with your provider.
Ready to Take the Next Step Toward Personalized Care?
Unlock the Insights That Could Transform Your Treatment!